How many stocks are there of Vita 34?
The current number of stocks of Vita 34 is 15.88 M undefined.
Vita 34 Stocks 2024
Vita 34 Stocks
15.88 M
Ticker
V3V.DE
ISIN
DE000A0BL849
WKN
A0BL84
In 2024, Vita 34 had 15.88 M outstanding stocks, a 0% change from the 15.88 M stocks in the previous year.
The Vita 34 Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2027e | 15.88 |
| 2026e | 15.88 |
| 2025e | 15.88 |
| 2024e | 15.88 |
| 2023 | 15.88 |
| 2022 | 15.83 |
| 2021 | 5.83 |
| 2020 | 4.1 |
| 2019 | 4.1 |
| 2018 | 4.08 |
| 2017 | 3.55 |
| 2016 | 3.05 |
| 2015 | 3.04 |
| 2014 | 3.11 |
| 2013 | 3.11 |
| 2012 | 2.92 |
| 2011 | 2.72 |
| 2010 | 2.72 |
| 2009 | 2.72 |
| 2008 | 2.72 |
| 2007 | 2.57 |
| 2006 | 2.1 |
| 2005 | 1.84 |
Vita 34 shares outstanding DE000A0BL849 · A0BL84
The number of shares was Vita 34 in 2023 — This indicates how many shares 15.881 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Vita 34 earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Vita 34's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Vita 34’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Vita 34's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 1.84 M Aktien |
| 2006 | 2.1 M Aktien |
| 2007 | 2.57 M Aktien |
| 2008 | 2.72 M Aktien |
| 2009 | 2.72 M Aktien |
| 2010 | 2.72 M Aktien |
| 2011 | 2.72 M Aktien |
| 2012 | 2.92 M Aktien |
| 2013 | 3.11 M Aktien |
| 2014 | 3.11 M Aktien |
| 2015 | 3.04 M Aktien |
| 2016 | 3.05 M Aktien |
| 2017 | 3.55 M Aktien |
| 2018 | 4.08 M Aktien |
| 2019 | 4.1 M Aktien |
| 2020 | 4.1 M Aktien |
| 2021 | 5.83 M Aktien |
| 2022 | 15.83 M Aktien |
| 2023 | 15.88 M Aktien |
| 2024e | 15.88 M Aktien |
| 2025e | 15.88 M Aktien |
| 2026e | 15.88 M Aktien |
| 2027e | 15.88 M Aktien |
Vita 34 Aktienanalyse
What does Vita 34 do?
Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Vita 34's Shares Outstanding
Vita 34's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Vita 34’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Vita 34’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Vita 34’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Vita 34 stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Vita 34 are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Vita 34 evolved in recent years?
The number of shares of Vita 34 has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Vita 34 as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Vita 34?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Vita 34 pay?
Over the past 12 months, Vita 34 paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 3.51 %. For the coming 12 months, Vita 34 is expected to pay a dividend of 0 EUR.
What is the dividend yield of Vita 34?
The current dividend yield of Vita 34 is 3.51 %.
When does Vita 34 pay dividends?
Vita 34 pays a quarterly dividend. This is distributed in the months of September, July, June, July.
How secure is the dividend of Vita 34?
Vita 34 paid dividends every year for the past 0 years.
What is the dividend of Vita 34?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Vita 34 located?
Vita 34 is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vita 34 from 6/7/2019 amounting to 0.16 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2019.
When did Vita 34 pay the last dividend?
The last dividend was paid out on 6/7/2019.
What was the dividend of Vita 34 in the year 2023?
In the year 2023, Vita 34 distributed 0 EUR as dividends.
In which currency does Vita 34 pay out the dividend?
The dividends of Vita 34 are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Vita 34 stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Vita 34
Our stock analysis for Vita 34 Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vita 34 Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
